| scholarly article | Q13442814 |
| P50 | author | Richard B. Lipton | Q56957375 |
| P2093 | author name string | Stephen D Silberstein | |
| Ellen B Dennehy | |||
| Stewart J Tepper | |||
| Sherie A Dowsett | |||
| Noah L Rosen | |||
| Erin Doty | |||
| P2860 | cites work | Driver sleepiness and risk of serious injury to car occupants: population based case control study | Q24522229 |
| Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society | Q24633523 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force | Q28256451 | ||
| Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review. | Q30248258 | ||
| Vehicle accidents related to sleep: a review | Q33725784 | ||
| Driving and diabetes: problems, licensing restrictions and recommendations for safe driving | Q33802157 | ||
| The triggers or precipitants of the acute migraine attack | Q34614780 | ||
| Epidemiology of vertigo, migraine and vestibular migraine | Q34947749 | ||
| A review of the neuropsychological effects of commonly used prescription medications | Q35573104 | ||
| Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality | Q35675690 | ||
| Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic | Q35720124 | ||
| Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms | Q35779019 | ||
| Neck pain in episodic migraine: premonitory symptom or part of the attack? | Q36017057 | ||
| On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers | Q36744112 | ||
| The migraine postdrome: An electronic diary study | Q37113371 | ||
| Medications and impaired driving | Q37662640 | ||
| The effect of pain on cognitive function: a review of clinical and preclinical research | Q37826944 | ||
| Evidence-based review on epilepsy and driving. | Q37974041 | ||
| The effects of most commonly prescribed second generation antidepressants on driving ability: a systematic review : 70th Birthday Prof. Riederer | Q38017603 | ||
| The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies | Q38323922 | ||
| Cognitive dysfunction during migraine attacks: a study on migraine without aura | Q38422117 | ||
| Quality of life in primary headache disorders: A review | Q38427435 | ||
| Clinical description of attack-related cognitive symptoms in migraine: A systematic review | Q38605500 | ||
| Neuropsychological assessment in migraine patients: a descriptive review on cognitive implications | Q38768696 | ||
| Topiramate in Migraine Prevention: A 2016 Perspective | Q39024628 | ||
| Sleep disturbance and affective comorbidity among episodic migraineurs | Q39394955 | ||
| Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial | Q39886402 | ||
| Effect of valvular heart diseases, migraine headaches, and perianal diseases on the risk of involvement in motor vehicle crashes | Q40965398 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. | Q41689462 | ||
| Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study | Q43586102 | ||
| Butalbital and driving impairment | Q43684918 | ||
| Migraine prevalence, disease burden, and the need for preventive therapy | Q43983035 | ||
| Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey | Q44238527 | ||
| Self-reported issues with driving in patients with chronic pain | Q44275465 | ||
| Opioid dose and risk of road trauma in Canada: a population-based study. | Q44337505 | ||
| Vestibular Dysfunction and Difficulty with Driving: Data from the 2001-2004 National Health and Nutrition Examination Surveys | Q46178588 | ||
| The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study. | Q46531151 | ||
| Driving disability and dizziness | Q47365669 | ||
| Cognitive impairment and quality of life in patients with migraine-associated vertigo | Q47604326 | ||
| Sleep-deprived motor vehicle operators are unfit to drive: a multidisciplinary expert consensus statement on drowsy driving | Q47851701 | ||
| Premonitory symptoms in migraine: an electronic diary study | Q48015914 | ||
| Development of the Cogniphobia Scale for Headache Disorders (CS-HD): A pilot study. | Q48308336 | ||
| Sleepiness, driving, and motor vehicle crashes. Council on Scientific Affairs, American Medical Association | Q48795109 | ||
| Effect of chronic nonmalignant pain on highway driving performance | Q48938577 | ||
| The King-Devick test and sports-related concussion: study of a rapid visual screening tool in a collegiate cohort | Q48945734 | ||
| The Impact of Sleep Disorders on Driving Safety - Findings from the SHRP 2 Naturalistic Driving Study. | Q50108246 | ||
| Functioning and disability in migraine. | Q51846641 | ||
| Epilepsy, antiepileptic drugs, and serious transport accidents: A nationwide cohort study. | Q52680913 | ||
| Vestibular migraine: diagnostic criteria. | Q52886117 | ||
| Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life | Q57091886 | ||
| Migraine: a risk factor for motor vehicle driver injury? | Q73746377 | ||
| A pilot study to measure cognitive efficiency during migraine | Q74261578 | ||
| Medical conditions, medication use, and their relationship with subsequent motor vehicle injuries: examination of the Canadian National Population Health Survey | Q84165713 | ||
| Migraine | Q88012546 | ||
| Cognitive dysfunction and migraine | Q93155336 | ||
| Migraine associated with road traffic accidents in United Arab Emirates | Q95456450 | ||
| National Highway Traffic Safety Administration (NHTSA) notes. Drugged driving expert panel report: a consensus protocol for assessing the potential of drugs to impair driving | Q95805367 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 178-189 | |
| P577 | publication date | 2019-12-02 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings | |
| P478 | volume | 60 |
Search more.